Results 41 to 50 of about 6,645 (195)

Dupilumab for the treatment of prurigo nodularis: A systematic review

Frontiers in Immunology, 2023
BackgroundConventional treatment techniques have limited efficacy and more side effects in the treatment of prurigo nodularis. The better alternative treatment option for better outcomes of the disease is dupilumab.ObjectiveThe objective of this study ...
Peng Cao, Peng Cao, Wenjing Xu, Wenjing Xu, Shuyi Jiang, Shuyi Jiang, Litao Zhang   +6 more
doaj   +1 more source

Biopsychosocial factors associated with prurigo nodularis in endogenous eczema

Indian Journal of Dermatology, 2015
Background: Prurigo nodularis is a dermatological manifestation secondary to chronic scratching or picking on focal areas of the skin. Its pathogenesis remains poorly understood, and limited data has indicated its association with psychological factors ...
Choon Chiat Oh, Huihua Li, Wellington Lee, Hong Liang Tey   +3 more
doaj   +1 more source

Fototerapia en el prurigo nodular. Experiencia propia y revisión de la literatura

Actas Dermo-Sifiliográficas, 2021
Resumen: Antecedentes y objetivo: El prurigo nodular (PN) es una dermatosis inflamatoria crónica caracterizada por la presencia de lesiones nodulares, intensamente pruriginosas, con gran impacto en la calidad de vida. El intenso prurito y el rascado son
A. Arrieta, A. Jaka, E. del Alcázar, M. Blanco, J.M. Carrascosa   +4 more
doaj   +1 more source

Successful Treatment of Severe Adult Linear IgA Dermatosis Using Dupilumab

JEADV Clinical Practice, EarlyView.
ABSTRACT Linear IgA dermatosis (LAD) is a rare autoimmune subepidermal bullous dermatosis, characterised by the presence of erythematous vesiculobullous lesions arranged in rosettes or herpetiform clusters. The standard treatment involves the administration of dapsone, followed by sulfasalazine, and general corticosteroid therapy, often in combination ...
Célia Delesalle, Claire Abasq‐Thomas, Claire Bocciarelli, Amélie Bourhis, Marina Alexandre, Belen Eguia, Laurent Misery, Numa Deydier   +7 more
wiley   +1 more source

Successful Use of Tofacitinib in Paediatric Prurigo Nodularis: A Report of Four Cases.

Indian J Dermatol
Gowda SK, Ameta B, Garg S, Behera B.
europepmc   +2 more sources

Prurigo nodularis after acupuncture [PDF]

JAAD Case Reports, 2015
Prurigo nodularis (PN) is a difficult-to-treat, chronic skin disorder characterized by the eruption of pruritic, hyperkeratotic nodules of the extensor surfaces.1 Here, we describe a patient who presented to our clinic with symptomatic, biopsy-proven PN shortly after acupuncture therapy.
Almazan, Timothy Hermosura, Jung, Jae Yeon   +1 more
openaire   +2 more sources

Clinical Characteristics and Risk Factors for Cutaneous Manifestations Associated With Nemolizumab in Atopic Dermatitis: A Multicenter Retrospective Study in Japan

The Journal of Dermatology, EarlyView.
ABSTRACT Nemolizumab, an anti‐interleukin‐31 receptor A monoclonal antibody, has been approved in Japan for treating atopic dermatitis (AD)‐associated pruritus. While it is effective for itch control, nemolizumab‐associated cutaneous adverse events have been increasingly recognized, yet their clinical features remain poorly characterized. In this study,
Wataru Sasaki, Ryo Saito, Kenta Suzuki, Daisuke Watanabe, Masako Minami‐Hori, Hirofumi Kamada, Hiroo Amano, Akihiko Uchiyama, Sei‐ichiro Motegi, Machiko Kamura, Kazunari Sugita, Noriko Kubota, Toshifumi Nomura, Maki Ozawa, Toshiya Takahashi, Takashi Yamakita, Kazumitsu Sugiura, Tetsuharu Ikegami, Ken Igawa, Yuka Kimura, Yoko Kataoka, Ryoichi Kamide, Masakazu Takahashi, Akio Tanaka, Mariko Sugawara‐Mikami   +24 more
wiley   +1 more source

Upadacitinib for prurigo nodularis

JAAD Case Reports
Clara Muntaner-Virgili, MD, Carlos Moreno-Vilchez, MD, Clara Torrecilla-Vall-Llossera, MD, Ignasi Figueras-Nart, MD   +3 more
openaire   +4 more sources

Comorbid Chronic Rhinosinusitis and Asthma: Shared Risk Factors and Treatment Implications—An EAACI Task Force Report

Allergy, EarlyView.
ABSTRACT Chronic rhinosinusitis (CRS) and asthma are prevalent conditions that often coexist. These diseases share common inflammatory mechanisms, such as T‐helper cell 2 (T2)‐high inflammation, driven by interleukin (IL)‐4, IL‐5, and IL‐13 cytokines.
Sanna Toppila‐Salmi, Sietze Reitsma, Valérie Hox, Simon Gane, Philippe Gevaert, Juan Maza‐Solano, Alma Helevä, Ida Sulku, Kaisa Santala, Iiris Kangasniemi, Ludger Klimek, Adam Chaker, Aspasia Karavelia, Michael Rudenko, Oliver Pfaar, Laura Van Gerven, Shaari Ariana, Michele Schiappoli, Marie Lundberg, Jan Hagemann, Ibon Eguíluz‐Gracia, Andre Moreira   +21 more
wiley   +1 more source

Recurrent prurigo nodularis related to infected tonsils: a case report

Journal of Medical Case Reports, 2008
Introduction Prurigo nodularis is an unusual disorder of unknown aetiology, which is notoriously resistant to therapy, and is characterized by extremely pruritic nodules with well-defined clinical symptoms and histopathological findings.
Katotomichelakis Michael, Balatsouras Dimitrios G, Bassioukas Konstantinos, Kontogiannis Nikolaos, Simopoulos Konstantinos, Danielides Vassilios   +5 more
doaj   +1 more source